MedTrace Logo

Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer

NCT03413930 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-02-17

No results posted yet for this study

Summary

This study is designed to evaluate the short-term and long-term results after transanal total mesorectal excision (TaTME) for the resection of mid and low rectal cancer compared with laparoscopic total mesorectal excision（LaTME）.

Conditions

Interventions

PROCEDURE

Transanal total mesorectal excision

Patients undergo transanal total mesorectal excision.（assisted by laparoscopy to control the IMA）

PROCEDURE

Laparoscopic total mesorectal excision

Patients undergo Laparoscopic total mesorectal excision.

Sponsors & Collaborators

  • Ruijin Hospital

    lead OTHER

Principal Investigators

  • Yimei Jiang, MD · Ruijin Hospitla North

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-30
Primary Completion
2021-03-31
Completion
2026-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03413930 on ClinicalTrials.gov